Endothelial and non-endothelial coronary blood flow reserve and left ventricular dysfunction in systemic hypertension

Clinics

Volumn 64, Issue 4, 2009, Pages 327-335

  Rocha, Aloísio Marchi ^a   Salemi, Vera Maria Cury ^a   Neto, Pedro Alves Lemos ^a   Matsumoto, Afonso Yoshikiro ^a   Pereira, Valéria Fontenelle Angelim ^a   Fernandes, Fábio ^a   Nastari, Luciano ^a   Mady, Charles ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acetylcholine; Adenosine; Coronary blood flow reserve; Heart failure; Hypertension

Indexed keywords

ACETYLCHOLINE; ADENOSINE; VASODILATOR AGENT;

ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADENOSINE; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASODILATION; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67650576121     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000400011     Document Type: Article

References (25)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. Frolich ED. Risk mechanismsin hypertensive heart disease. Hypertension 1999;34:782-9.
3. Hamasaki S, Suwaidi JA, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000;35:1654-60.
4. Antony I, Nitenberg A, Foult J-M, Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993;.22:514-20.
5. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, et al. Endothelium-dependent dilatation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990;81:772-9.
6. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
7. The 7th Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure - JNC VII. JAMA 2003;289:1560-72.
8. Duffy SJ, Castle SF, Harper RW, Meredith MB. Contribution of prostanoids and nitric oxide to resting flow, metabolic vasodilatation, and flow-mediated dilatation in human coronary circulation. Circulation 1999;100:1951-7.
9. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(12):1440-63.
10. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall stress and mass by echocardiography. Circulation 1972;45:602-11.
11. Reichek N, Wilson J, St John-Suton M, Plappert TA, Goldberg S, Hirshfeld JW. Noninvasive determination of left ventricular systolic stress: validation of the method and initial application. Circulation 1982;65:99-108.
12. Ganz W, Swan HJC. Measurement of blood flow by thermodilution. Am J Cardiol 1972;29:241-6.
13. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-911.
14. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-43.
15. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
16. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
17. Reis SE, Holubkov R, Lee JS, Sharaf B, Reichek N, Rogers WJ, et al; for the WISE Investigators. Coronary flow velocity responses to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 1999;33:1469-75.
18. Hollenberg SM, Tamburro P, Johnson MR, Burns DE, Spokas D, Costanzo MR, et al. Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow-mediated from receptor-mediated endothelial responses. Cathet Cardiovasc Intervent 1999;46:282-8.
19. Feldman RL, Marx JD, Pepine CJ, Conti CR. Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 1982;66:321-327.
20. Strauer BE. The coronary circulation in hypertensive heart disease. Hypertension 1984;6(suppl):74-80.
21. Schiffrin EL, Pu Q, Park JQ. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens 2002;15:105-10.
22. Bracht C, Yan XW, Brunner-LaRocca HP, Sutsch G, Amann FW, Kiowski W. Isradipine improves endothelium-dependent vasodilation in normotensive coronary artery disease patients with hypercholesterolemia. J Hypertens 2001;19:899-905.
23. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, et al. Angiotensin-converting enzymeinhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation 1996;94:258-65.
24. Kamezaki F, Tasaki H, Yamashita K, Shibata K, Hirakawa N, Tsutsui M, et al. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker. Hypertens Res 2007;30(8):699-706.
25. Bottcher M, Botker HW, Sonne H, Nielsen TT, Czernin J. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. Circulation 1999;99:1795-801.